Micro Imaging Technology Receives a Significant Verification Report from an Independent and Internationally Recognized Testing Laboratory.LAGUNA HILLS, Calif. -- Micro Imaging Technology ("MIT MIT - Massachusetts Institute of Technology "), formerly Electropure Inc. (Pink Sheets:ELTP ELTP Emergency Leave Transfer Program (US government) ), announced the receipt of a report from an independent and internationally recognized biological testing laboratory. During October 2005, MIT contracted with North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Science Associates Inc. ("NAMSA NAMSA NATO Maintenance and Supply Agency ") to design and perform a verification test that compares the speed, accuracy and efficiency of MIT's rapid microbe microbe /mi·crobe/ (mi´krob) a microorganism, especially a pathogenic one such as a bacterium, protozoan, or fungus.micro´bialmicro´bic mi·crobe n. identification system with conventional processes. The comparative tests were in a double-blind experiment, meaning that the independent laboratory technicians, using the MIT System and a well-recognized alternative, were not aware of the various microbes' identification. NAMSA chose the industry-standard MIDI Sherlock Microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. Identification System ("MIDI") as the initial process to verify the accuracy of MIT's diagnostic capabilities. The MIDI system identifies bacteria and yeast based on gas chromatographic chro·mat·o·graph n. An instrument that produces a chromatogram. tr.v. chro·mat·o·graphed, chro·mat·o·graph·ing, chro·mat·o·graphs To separate and analyze by chromatography. analysis of fatty acid methyl esters. The MIT system scored 98 percent correct identifications in 50 tests, with each test consuming several minutes for sample preparation and an average three minutes for testing. The gas chromatographic system was correct 80 percent and failed to identify, with several attempts, one bacterium. NAMSA employed a conventional biological testing method which matched the bacterium with the MIT identification. The gas chromatographic system took hours per test and the biological testing method required days. David Haavig, Ph.D., MIT's chief scientist and general manager, stated that, "We are extremely pleased with all aspects of the independent test results and report." MIT initiated "Proof-of-Principle" testing in 1998 and by the end of 1999 had developed and continues to improve a patented laser-based technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape, and external and internal optical characteristics of the microbe. By measuring the scattered light at specific angles, the system can detect and differentiate objects the size of bacteria. MIT has demonstrated the ability to detect and immediately identify the microbes Escherichia coli Escherichia coli (ĕsh'ərĭk`ēə kō`lī), common bacterium that normally inhabits the intestinal tracts of humans and animals, but can cause infection in other parts of the body, especially the urinary tract. , Listeria Listeria /Lis·te·ria/ (lis-ter´e-ah) a genus of gram-negative bacteria (family Corynebacterium); L. monocyto´genes causes listeriosis. Lis·te·ri·a n. , Salmonella Staphylococcus aureus, Shigella shigella Any of the rod-shaped bacteria that make up the genus Shigella, which are normal inhabitants of the human intestinal tract and can cause dysentery, or shigellosis. Shigellae are gram-negative (see gram stain), non-spore-forming, stationary bacteria. S. and other pathogenic bacteria. North American Science Associates Inc. has been, for over 35 years, one of the world's leading independent laboratories specializing in the safety evaluation of medical devices. NAMSA offers testing services and products to device manufacturers, raw material suppliers, pharmaceutical companies, sterilizers and other related industries -- primarily serving the health care industry. Safe Harbor Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and 1995: Information and announcements in this release involve Micro Imaging Technology's expectations, beliefs, hopes, plans, intentions or strategies regarding the future and forward-looking statements included in this release are based upon information available to Micro Imaging Technology's as of the date of the release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; difficulties in assimilating companies previously acquired; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time in Micro Imaging Technology's financial reports filed with the SEC. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion